ENVUE MEDICAL INC (FEED) Stock Price & Overview
NASDAQ:FEED • US63008J8844
Current stock price
The current stock price of FEED is 1.83 USD. Today FEED is up by 0.55%. In the past month the price decreased by -5.7%.
FEED Key Statistics
- Market Cap
- 1.995M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -83.93
- Dividend Yield
- N/A
FEED Stock Performance
FEED Stock Chart
FEED Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to FEED.
FEED Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to FEED. FEED may be in some trouble as it scores bad on both profitability and health.
FEED Earnings
FEED Forecast & Estimates
FEED Groups
Sector & Classification
FEED Financial Highlights
Over the last trailing twelve months FEED reported a non-GAAP Earnings per Share(EPS) of -83.93. The EPS decreased by -25.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.54% | ||
| ROE | -13.4% | ||
| Debt/Equity | 0.05 |
FEED Ownership
FEED Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.04 | 176.947B | ||
| ISRG | INTUITIVE SURGICAL INC | 45.59 | 160.874B | ||
| SYK | STRYKER CORP | 22.37 | 127.08B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.86 | 91.793B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.3 | 46.952B | ||
| IDXX | IDEXX LABORATORIES INC | 39.94 | 45.766B | ||
| BDX | BECTON DICKINSON AND CO | 11.51 | 44.123B | ||
| RMD | RESMED INC | 18.9 | 32.931B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.24 | 31.779B | ||
| DXCM | DEXCOM INC | 25.83 | 24.289B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.882B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.79 | 14.253B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About FEED
Company Profile
ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.
Company Info
IPO: 2015-04-24
ENVUE MEDICAL INC
969 Pruitt Ave,
Tyler TEXAS US
Employees: 15
Phone: 19142333004
ENVUE MEDICAL INC / FEED FAQ
Can you describe the business of ENVUE MEDICAL INC?
ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. Its segments include NanoVibronix, ENvue and Corporate. NanoVibronix is engaged in selling its products directly to patients as well as through distributor agreements. ENvue is engaged in selling its systems and Nasoenteral tubes and related services. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract.
What is the current price of FEED stock?
The current stock price of FEED is 1.83 USD. The price increased by 0.55% in the last trading session.
What is the dividend status of ENVUE MEDICAL INC?
FEED does not pay a dividend.
What is the ChartMill technical and fundamental rating of FEED stock?
FEED has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the short interest for FEED stock?
The outstanding short interest for ENVUE MEDICAL INC (FEED) is 10.56% of its float.